Bodal Chemicals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹588.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.11 per cent from ₹489.57 crore. This corresponds to a year-on-year *(YoY) growth of 30.42 per cent.
Operating Profit
Operating Profit stands at ₹68.57 crore, reflecting a quarter-on-quarter *(QoQ) increase of 211.12 per cent from ₹22.04 crore. This corresponds to a year-on-year *(YoY) growth of 45.12 per cent.
PBDT
PBDT stands at ₹53.32 crore, reflecting a quarter-on-quarter *(QoQ) increase of 201.24 per cent from ₹17.70 crore. This corresponds to a year-on-year *(YoY) growth of 86.43 per cent.
Profit Before Tax
Profit Before Tax stands at ₹36.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14,929.17 per cent from ₹0.24 crore. This corresponds to a year-on-year *(YoY) growth of 211.22 per cent.
Net Profit
Net Profit stands at ₹32.06 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13,258.33 per cent from ₹0.24 crore. This represents a 121.10 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bodal Chemicals Ltd Earnings
- YOY
- QOQ
Bodal Chemicals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bodal Chemicals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bodal Chemicals Ltd Financial Reports
Bodal Chemicals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bodal Chemicals | 3.18% | 4.58% | 2.10% | 1.52% | 45.73% | -8.64% |
| Amal | 6.29% | -4.53% | 32.40% | 39.71% | 60.32% | -25.87% |
| Fairchem Organic | -3.03% | 6.38% | 17.74% | 31.03% | 16.49% | -18.02% |
| Gem Aromatics | 1.13% | -3.48% | -2.82% | 7.73% | 17.96% | -43.90% |
| Sr.Rayala.Hypo | -1.23% | -2.09% | -2.20% | -4.74% | 6.71% | -25.51% |
| Sadhana Nitro | -1.80% | 3.80% | -7.14% | 14.23% | 72.78% | 35.15% |
| Anlon Healthcare | -0.20% | -0.13% | -8.09% | 5.26% | 19.05% | 63.58% |
Company Info
Company Information
CMD & CEO : Suresh J Patel
Executive Director : Bhavin S Patel
Executive Director : Ankit S Patel
Executive Director : Rajarshi Ghosh
Independent Non Exe. Director : Nalin Kumar
Independent Non Exe. Director : Neha Huddar
Independent Non Exe. Director : MAYANK KULINCHANDRA MEHTA
Independent Non Exe. Director : Rohit Maloo
Company Sec. & Compli. Officer : Ashutosh B Bhatt